Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank67
3Y CAGR+40.6%
5Y CAGR-10.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+40.6%/yr
Annual compound
5Y CAGR
-10.2%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $61.15M | +46.8% |
| 2024 | $41.67M | -51.6% |
| 2023 | $86.10M | +291.5% |
| 2022 | $21.99M | +41.3% |
| 2021 | $15.57M | -85.2% |
| 2020 | $104.92M | +343.6% |
| 2019 | $23.65M | - |